Regent Pacific Group Ltd. Share Price Hong Kong S.E.
Equities
0575
KYG7478U1388
Pharmaceuticals
Sales 2022 | 35T 3L 29.23L | Sales 2023 | 3L 22.73L 2.43Cr | Capitalization | 1.81Cr 14Cr 151.43Cr |
---|---|---|---|---|---|
Net income 2022 | -3.6Cr -28Cr -300.61Cr | Net income 2023 | -2.5Cr -20Cr -208.76Cr | EV / Sales 2022 | 1,045 x |
Net Debt 2022 | 1.23Cr 9.6Cr 102.64Cr | Net cash position 2023 | 12.2L 95.3L 10Cr | EV / Sales 2023 | 58.1 x |
P/E ratio 2022 |
-0.67
x | P/E ratio 2023 |
-0.71
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 40.23% |
Managers | Title | Age | Since |
---|---|---|---|
Jamie Gibson
CEO | Chief Executive Officer | 58 | 01/96/01 |
Jim Mellon
FOU | Founder | 68 | 01/90/01 |
Yui Fui Wong
DFI | Director of Finance/CFO | 49 | 01/11/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jim Mellon
FOU | Founder | 68 | 01/90/01 |
Jamie Gibson
CEO | Chief Executive Officer | 58 | 01/96/01 |
Stawell Searle
BRD | Director/Board Member | 80 | 01/01/01 |
1st Jan change | Capi. | |
---|---|---|
+55.55% | 82TCr | |
+39.71% | 63TCr | |
-6.83% | 35TCr | |
+17.15% | 32TCr | |
+7.09% | 29TCr | |
+13.64% | 24TCr | |
+1.06% | 22TCr | |
+13.04% | 22TCr | |
+7.87% | 17TCr |